Akero Therapeutics (AKRO) And 89bio (ETNB) CRASH Today – What’s Lies Ahead For Them?


In a shocking turn of events, shares of Akero Therapeutics (AKRO) and 89bio (ETNB) took a nosedive on Tuesday, leaving investors in a state of panic. The immediate cause? Akero’s liver-disease treatment, aimed at tackling the severe condition of nonalcoholic steatohepatitis (NASH), didn’t quite live up to expectations in a midstage study, sending AKRO stock … Read more